INTERCEPT PHARMACEUTICALS INC

Profile

Company Names

INTERCEPT PHARMACEUTICALS INC

Addresses

18 DESBROSSES STREET, NEW YORK, NY 10013

Phone Numbers

646-747-1000

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$30,000,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2012-08-09 
$30,000,000.00 
$50,000,000.00 
$20,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LUCIANO 
 
ADORINI 
EXECUTIVE OFFICER
INTERCEPT PHARMACEUTICALS INC
BARBARA 
 
DUNCAN 
EXECUTIVE OFFICER
EDGEMONT PHARMACEUTICALS, LLC   |  INTERCEPT PHARMACEUTICALS INC   |  MEDGENICS, INC.   |  AEVI GENOMIC MEDICINE, INC.   |  JOUNCE THERAPEUTICS, INC.
PAOLO 
 
FUNDARO 
DIRECTOR
INTERCEPT PHARMACEUTICALS INC   |  IONCOLOGI, INC.
MARK 
E. 
PRUZANSKI 
EXECUTIVE OFFICER, DIRECTOR
INTERCEPT PHARMACEUTICALS INC
DAVID 
 
SHAPIRO 
EXECUTIVE OFFICER
ALTAIR THERAPEUTICS, INC.   |  WELLPARTNER INC   |  INTERCEPT PHARMACEUTICALS INC   |  KPS SPECIAL SITUATIONS FUND IV, LP   |  KPS SPECIAL SITUATIONS FUND IV (A), LP   |  KPS SPECIAL SITUATIONS FUND IV (B), LP   |  SCOUT SECURITY, INC.   |  VANSHAP CAPITAL VALUE FUND, LP   |  PROPEL MEDIA, INC.   |  FIRST LIGHT BIOSCIENCES INC.   |  ARCTURUS THERAPEUTICS LTD.   |  GALECTO, INC.   |  VANSHAP CAPITAL FOOD TECHNOLOGY FUND I, LP   |  SCOUT SECURITY LTD   |  OPEN UNICORN SPV SPACEX 1, LP   |  OPEN UNICORN FUND, LP   |  AV APEX FUND, LP   |  AV APEX FUND-A, LP   |  KPS SPECIAL SITUATIONS FUND VI (EXECUTIVE), LP   |  KPS AS CO-INVEST, LP   |  OPEN SPX II, LP   |  OPEN OAI I, LP
JONATHAN 
T. 
SILVERSTEIN 
DIRECTOR
CADUCEUS PRIVATE INVESTMENTS IV, LP   |  GLAUKOS CORP   |  CADUCEUS CAPITAL II, L.P.   |  CADUCEUS CAPITAL, L.P.   |  ORBIMED ISRAEL PARTNERS LIMITED PARTNERSHIP   |  INTERCEPT PHARMACEUTICALS INC   |  ORBIMED PARTNERS II, L.P.   |  ORBIMED PARTNERS, L.P.   |  ORBIMED PRIVATE INVESTMENTS V, LP   |  ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.   |  ORBIMED GLOBAL HEALTHCARE FUND, L.P.   |  ORBIMED ROYALTY OPPORTUNITIES II, LP   |  ORBIMED ASIA PARTNERS III, L.P.   |  ORBIMED ROYALTY + CREDIT OPPORTUNITIES III, LP   |  ORBIMED GENESIS FUND, L.P.   |  ORBIMED NEW HORIZONS FUND, L.P.   |  ORBIMED ASIA PARTNERS IV, L.P.
LORENZO 
 
TALLARIGO 
DIRECTOR
INTERCEPT PHARMACEUTICALS INC
KLAUS 
 
VEITINGER 
DIRECTOR
PROMENTIS PHARMACEUTICALS, INC.   |  BIOLEX THERAPEUTICS, INC.   |  RELYPSA INC   |  INTERCEPT PHARMACEUTICALS INC   |  SYMBIOMIX THERAPEUTICS, LLC   |  TRICIDA, INC.   |  CRANIOVATION, INC.   |  SPARROW PHARMACEUTICALS, INC.   |  NEUROGASTRX, INC.   |  ALPHEUS MEDICAL, INC.
KLAUS 
 
VELTINGER 
DIRECTOR
INTERCEPT PHARMACEUTICALS INC
NICOLE 
 
WILLIAMS 
DIRECTOR
INTERCEPT PHARMACEUTICALS INC   |  SENESTECH, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-09-04
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-08-09 
2012-08-24
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-08-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#